This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
Momelotinib, an oral JAK1/2 inhibitor for myelofibrosis, is going to GSK as part of a $1.9 billion acquisition of Sierra…
Article
11 months ago ●
6 mins read
Context. ICeD-2 (Merck) is a dipeptidyl peptidase 9 (DPP9) inhibitor under development for HIV-1 infections. Despite the significant advancements in…
molecule
5 months ago ●
4 mins read
It was great to see over 100 drug hunters at our first drug discovery webinar! You can find the video…
Article
11 months ago ●
1 min read
Context. GB1211 (Galecto Biotech) is an oral galectin-3 inhibitor under development for fibrotic disease. First described in 1971, galectin-3, a…
molecule
5 months ago ●
5 mins read
What were the billion-dollar small molecules in 2021? This article and infographic, which is part 3 of a Premium series…
Article
11 months ago ●
2 mins read
Context. GST-HG131 (WuXi AppTec) is an oral hepatitis B virus (HBV) inhibitor which lowers hepatitis B antigen (HBsAg) levels which…
molecule
5 months ago ●
5 mins read
Load More
